首页 | 本学科首页   官方微博 | 高级检索  
     

呼吸道苛养菌对头孢妥仑匹酯等10种抗菌药物的药敏监测
引用本文:袁锦屏,杨灵,邱桂霞,麦颖. 呼吸道苛养菌对头孢妥仑匹酯等10种抗菌药物的药敏监测[J]. 中国感染控制杂志, 2011, 10(4): 289-291
作者姓名:袁锦屏  杨灵  邱桂霞  麦颖
作者单位:呼吸道苛养菌对头孢妥仑匹酯等10种抗菌药物的药敏监测
基金项目:致谢:感谢日本明治制果株式会社、长澳药业科技集团下属深圳联诚医药有限公司赞助的药敏试验相关试剂
摘    要:目的了解呼吸道感染苛养菌的分离及其对头孢妥仑匹酯等10种抗菌药物的药敏情况,为临床治疗提供参考。方法收集2005年、2007年、2008年及2010年1-6月从呼吸道细菌感染患者送检的痰标本中分离的苛养菌,采用美国临床实验室标准化研究所推荐的K B法检测头孢妥仑匹酯等10种抗菌药物对其的体外抗菌活性。结果438例患者共分离苛养菌462株,其产β 内酰胺酶率:流感嗜血杆菌23.62%(30/127),副流感嗜血杆菌2.51%(5/199),卡他莫拉菌41.58%(42/101),未发现对青霉素中介或耐药的肺炎链球菌。流感嗜血杆菌、副流感嗜血杆菌、卡他莫拉菌及肺炎链球菌对头孢妥仑匹酯的敏感率分别为96.30%、94.36%、100.00%、100.00%;流感嗜血杆菌和副流感嗜血杆菌对头孢噻肟、头孢呋辛、头孢克罗、头孢唑林的敏感率为83.59%~93.33%,对阿莫西林/克拉维酸的敏感率分别为91.67%、88.21%;卡他莫拉菌、肺炎链球菌对阿莫西林/克拉维酸的敏感率为100.00%;对克拉霉素的敏感率,流感嗜血杆菌为87.96%,其他3种菌为34.29%~59.00%;4种苛养菌对四环素的敏感率较低,为22.86%~63.00%;流感嗜血杆菌、副流感嗜血杆菌、卡他莫拉菌对复方磺胺甲口恶唑的耐药率高,达54.63%~73.33%。结论头孢妥仑匹酯对呼吸道感染的苛养菌具有很强的抗菌活性;临床医生应根据药敏试验结果合理使用抗菌药物,以减少耐药菌的产生。

关 键 词:头孢妥仑匹酯;呼吸道感染 ;苛养菌;抗菌药物;抗药性  微生物;微生物敏感性试验  
收稿时间:2010-10-29
修稿时间:2010-12-22

Susceptibility of cefditoren pivoxil and other nine antimicrobial agents against fastidious bacteria isolated from respiratory tract
YUAN Jin ping,YANG Ling,QIU Gui xi,MAI Ying. Susceptibility of cefditoren pivoxil and other nine antimicrobial agents against fastidious bacteria isolated from respiratory tract[J]. Chinese Journal of Infection Control, 2011, 10(4): 289-291
Authors:YUAN Jin ping  YANG Ling  QIU Gui xi  MAI Ying
Affiliation:National Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China
Abstract:Objective To realize the isolation status of fastidious bacteria causing respiratory tract infection and antimicrobial susceptibility of fastidious bacteria to cefditoren pivoxil as well as the other 9 antimicrobial agents, so as to provide reference for clinical treatment. Methods Fastidious bacteria isolated from sputum of patients with respiratory tract infection during the year of 2005, 2007, 2008, and January-June in 2010 were collected. Antimicrobial susceptibility of fastidious bacteria were tested with Kirby-Bauer method recommended by Clinical and Laboratory Standards Institute (CLSI). Results A total of 462 isolates were isolated from 438 patients, 13 lactamase-producing rate was as follows: Haemophilus influenzae (HI) 23.62% (30/127), Haemophilus parainfluenzae (HP) 2.51%(5/199), Moraxella catarrhalis (MC) 41. 58% (42/1/11), penicillin-resistant Streptococcus pneumoniae (SP) isolates was not found. The susceptibility rate (SR) of HI, HP, MC, and SP to cefditoren pivoxil was 96. 30~, 94. 36%, 100. 00%, and 100. 00%, respectively;The SR of HI and HP to cefotaxime, cefuroxime, eefaclor and cefazolin was 83.59% - 93. 33%, SR to amoxicillin/clavulanic acid was 91.67% and 88.21% respectively; SR of MC and SP to amoxicillin / clavulanic acid was 100. 01/%; SR of HI to elarithromyein was 87. 96%, SR of HP, SP and MC to clarithromycin was 34. 29% - 59. 00%; SR of 4 kinds of fastidious bacteria to tetracycline was 22.86G- 63. 005; The resistant rate of HI, HP and MC to trimethoprim/sulfamethoxazole was 54. 63%- 3.33%. Conclusion Cefditoren pivoxil has strong activity against fastidious bacteria causing respiratory tract infection; in order to reduce the emergence of drug resistant strain, clinicians should choose antimicrobial agents according to antimicrobial susceptibility test results.
Keywords:cefditoren pivoxil  respiratory tract infection  fastidious bacteria  antimicrobial agents  drug resistance, microbial  antimierobial susceptibility test
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号